Guardant Health, Inc.
GH
$85.49
$1.471.75%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -416.28M | -398.79M | -413.82M | -416.55M | -436.37M |
| Total Depreciation and Amortization | 39.74M | 40.14M | 41.33M | 41.91M | 42.39M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 206.21M | 185.30M | 192.55M | 194.44M | 214.99M |
| Change in Net Operating Assets | -14.43M | -49.55M | -58.61M | -92.07M | -60.86M |
| Cash from Operations | -184.76M | -222.90M | -238.55M | -272.26M | -239.86M |
| Capital Expenditure | -48.31M | -39.33M | -33.18M | -32.61M | -35.09M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -58.99M | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -519.91M | 327.73M | 41.10M | 46.10M | -226.22M |
| Cash from Investing | -627.20M | 288.40M | 7.92M | 13.49M | -261.31M |
| Total Debt Issued | 402.50M | 5.03M | 0.00 | 5.03M | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 377.81M | 18.76M | 15.05M | 15.39M | 14.84M |
| Repurchase of Common Stock | -75.55M | -78.22M | -78.83M | -74.64M | -15.68M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -33.63M | -9.40M | -7.28M | -12.55M | -153.00K |
| Cash from Financing | 671.13M | -63.83M | -71.05M | -66.77M | -996.00K |
| Foreign Exchange rate Adjustments | 491.00K | -518.00K | 1.92M | 141.00K | -1.77M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -140.34M | 1.15M | -299.76M | -325.40M | -503.93M |